Skip to main content
Premium Trial:

Request an Annual Quote

German Genome Center, Company to Combine Gene-Expression Services

NEW YORK, March 11 (GenomeWeb News) - The RZPD German Resource Center for Genome Research plans to combine its Affymetrix GeneChip services with the cell-type expression-profiling technology made by German neighbor Axaron Bioscience, the groups said today.

 

Axaron, based in Heidelberg, and Berlin-based RZPD intend to co-market their services in future, they said.

 

RZPD, an authorized Affymetrix partner, provides Affy services throughout Europe. Axaron sells its Axaminer service for gene-expression profiling. The technology comprises specific cell labeling, automated cell isolation using laser microdissection, isolation, and RNA amplification.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.